Global investment firm TPG has entered into a binding agreement to acquire a 35% stake in SCHOTT Poonawalla Pvt Ltd, a ...

Global investment firm TPG has signed a legally binding agreement to purchase a 35% ownership in SCHOTT Poonawalla, the joint venture between Serum Institute of India (SII) and Germany-based SCHOTT ...

Parents nationwide intend to sue Pune's Serum Institute of India (SII) and government officials responsible for the Covid vaccine rollout. They allege their children's deaths resulted from vaccine ...

Karan Johar made headlines when he sold a 50 percent stake of his production company, Dharma Productions, to Serum Institute ...

TPG, a leading global alternative asset management firm will acquire 35% stake in SCHOTT Poonawalla from Serum Institute of India (SII) SII will retain a minority stake in the company, with SCHOTT ...

TPG will acquire a 35% stake in SCHOTT Poonawalla from the Serum Institute of India. This joint venture with SCHOTT Pharma is ...

The transaction, funded through TPG Growth and co-investor Novo Holdings, is expected to close in the first half of 2025.

TPG, a global alternative asset management firm, has entered into a binding agreement to acquire a 35% stake in SCHOTT ...

TPG Growth, TPG’s middle market and growth equity platform, is funding the investment, along with Novo Holdings as a ...

TPG is acquiring a 35% stake in SCHOTT Poonawalla, a joint venture of SCHOTT Pharma and Serum Institute of India. The deal is ...

TPG has entered into a binding agreement to acquire 35% stake in Schott Poonawalla from Serum Institute of India (SII), said ...

SCHOTT Pharma, a pioneer in drug containment and delivery solutions has announced that TPG, a leading global alternative asset management firm, has entered into a binding agreement to acquire a 35% ...